-
AOT 2026 | Professor Hans H. Hirsch: Comprehensive Infection Prevention and Clinical Management for Post-Transplant Reintegration Into the Community
To comprehensively improve public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become key drivers of clinical progress. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT) was successfully held in Beijing from April 24 to 25, 2026. Organized by the…
-
CSCO BC 10th Anniversary Tribute | President Jinming Yu: A Decade of Growth and Remarkable Achievement — Looking Forward to CSCO BC Continuing to Shape a New Vision for Cancer Prevention and Care While Amplifying China’s Voice
As the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC) celebrates its 10th anniversary, the 2026 National Breast Cancer Conference was grandly held from April 10–12. More than an academic gathering, this conference served as both a comprehensive review of CSCO BC’s decade-long development and a forward-looking blueprint for the future…
-
CSCO BC Guidelines & Consensus | Professor Qiang Liu: Interpreting the Chinese Expert Consensus on the Diagnosis and Treatment of Young Breast Cancer (2025 Edition) — Optimizing Risk Stratification and Full-Cycle Management for Young Patients
The 2026 National Breast Cancer Conference was held in Beijing from April 10–12. During the meeting, Professor Qiang Liu from Sun Yat-sen Memorial Hospital, Sun Yat-sen University delivered a dedicated presentation on the Chinese Expert Consensus on the Diagnosis and Treatment of Young Breast Cancer (2025 Edition).
-
CSCO BC Guideline Highlights | Professor Man Li: Focusing on HER2-Low and HER2-Ultralow Breast Cancer — Key Updates and Practical Changes in the 2026 Guidelines
The 2026 National Breast Cancer Conference was successfully held in Beijing from April 10–12, during which the 2026 Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines were officially released. Oncology Frontier invited Professor Man Li from the Second Affiliated Hospital of Dalian Medical University to discuss three key clinical topics surrounding HER2-low and HER2-ultralow…
-
CSCO BC Guideline Highlights | Professor Shusen Wang: Key Updates in Advanced Triple-Negative Breast Cancer Management — From Salvage Chemotherapy to a New Era of Immunotherapy-Based Combination Strategies
The 2026 National Breast Cancer Conference was held in Beijing from April 10–12, during which the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2026 (CSCO BC Guidelines 2026) underwent a major update. At the meeting, Professor Shusen Wang from Sun Yat-sen University Cancer Center presented the latest revisions related to the management of…
-
Nature Communications Publishes Breakthrough Study Led by Academician Xu Binghe and Collaborators: China-Developed AKT Inhibitor Delivers Promising First-in-Human Results
On February 6, 2026, Nature Communications published online a study led by Academician Xu Binghe from the National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences. The single-arm Phase Ib trial evaluated the efficacy and safety of the novel oral pan-AKT inhibitor afuresertib combined with fulvestrant in previously treated patients with HR-positive/HER2-negative advanced…
-
A Decade of Pursuing Light, A Future Full of Hope: Tracing the Milestones and Defining Moments of CSCO BC
In April 2016, a pink seed took root in Beijing with the launch of preparations for the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC). Driven by vision, dedication, and perseverance, a group of Chinese physicians came together to support and empower patients with breast cancer through science, compassion, and unwavering…
-
Sino-French Breast Reconstruction Congress | Professor Hongyuan Li: Building a Bridge for Sino-French Collaboration and Advancing Breast Reconstruction Accessibility and De-escalation Strategies in Oncoplastic Surgery Through the “Chongqing Experience”
The 15th Sino-French Breast Reconstruction Congress and the 13th Sino-French Breast Cancer Academic Conference recently concluded successfully in Chongqing, China. During the meeting, Oncology Frontier conducted an exclusive interview with Professor Hongyuan Li from the First Affiliated Hospital of Chongqing Medical University (hereafter referred to as CQMU First Hospital), one of the conference’s principal organizers.…
Connecting Medical Expertise through Media